Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J. Matsuzaki A, et al. Among authors: yanai f. Int J Hematol. 2001 Apr;73(3):369-77. doi: 10.1007/BF02981964. Int J Hematol. 2001. PMID: 11345205 Review.
Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu-Yamaguchi Children's Cancer Study Group.
Moritake H, Kamimura S, Nunoi H, Nakayama H, Suminoe A, Inada H, Inagaki J, Yanai F, Okamoto Y, Shinkoda Y, Shimomura M, Itonaga N, Hotta N, Hidaka Y, Ohara O, Yanagimachi M, Nakajima N, Okamura J, Kawano Y. Moritake H, et al. Among authors: yanai f. Int J Hematol. 2014 Jul;100(1):70-8. doi: 10.1007/s12185-014-1591-1. Epub 2014 May 15. Int J Hematol. 2014. PMID: 24827398
Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C, et al. Matsuzaki A, et al. Among authors: yanai f. Med Pediatr Oncol. 1996 Jan;26(1):10-9. doi: 10.1002/(SICI)1096-911X(199601)26:1<10::AID-MPO2>3.0.CO;2-Y. Med Pediatr Oncol. 1996. PMID: 7494507
Treatment of standard-risk acute lymphoblastic leukemia in children: the results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A, Okamura J, Ishii E, Ikuno Y, Koga H, Eguchi H, Yanai F, Inada H, Nibu K, Hara T, Take H, Miyazaki S, Tasaka H. Matsuzaki A, et al. Among authors: yanai f. Pediatr Hematol Oncol. 1999 May-Jun;16(3):187-99. doi: 10.1080/088800199277245. Pediatr Hematol Oncol. 1999. PMID: 10326217 Clinical Trial.
Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: a report from the Kyushu-Yamaguchi Children's Cancer Study group in Japan.
Matsuzaki A, Eguchi H, Ikuno Y, Ayukawa H, Yanai F, Ishii E, Sugimoto T, Inada H, Anami K, Nibu K, Hara T, Miyazaki S, Okamura J. Matsuzaki A, et al. Among authors: yanai f. Pediatr Hematol Oncol. 2000 Dec;17(8):623-34. doi: 10.1080/08880010050211330. Pediatr Hematol Oncol. 2000. PMID: 11127394 Clinical Trial.
39 results